97 related articles for article (PubMed ID: 10599863)
1. Dopamine release in the prefrontal cortex in response to memantine following sub-chronic NMDA receptor blockade with memantine: a microdialysis study in rats.
Hesselink MB; De Boer AG; Breimer DD; Danysz W
J Neural Transm (Vienna); 1999; 106(9-10):803-18. PubMed ID: 10599863
[TBL] [Abstract][Full Text] [Related]
2. Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover.
Quack G; Hesselink M; Danysz W; Spanagel R
J Neural Transm Suppl; 1995; 46():97-105. PubMed ID: 8821045
[TBL] [Abstract][Full Text] [Related]
3. Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat--a pharmacokinetic microdialysis study.
Spanagel R; Eilbacher B; Wilke R
Eur J Pharmacol; 1994 Sep; 262(1-2):21-6. PubMed ID: 7813574
[TBL] [Abstract][Full Text] [Related]
4. Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity.
Del Arco A; Segovia G; Mora F
Psychopharmacology (Berl); 2008 Dec; 201(3):325-38. PubMed ID: 18751970
[TBL] [Abstract][Full Text] [Related]
5. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.
Balla A; Sershen H; Serra M; Koneru R; Javitt DC
Neuropsychopharmacology; 2003 Jan; 28(1):34-44. PubMed ID: 12496938
[TBL] [Abstract][Full Text] [Related]
6. Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration.
Hesselink MB; Smolders H; De Boer AG; Breimer DD; Danysz W
Behav Pharmacol; 1999 Feb; 10(1):85-98. PubMed ID: 10780305
[TBL] [Abstract][Full Text] [Related]
7. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
[TBL] [Abstract][Full Text] [Related]
8. Brain penetration and in vivo recovery of NMDA receptor antagonists amantadine and memantine: a quantitative microdialysis study.
Hesselink MB; De Boer BG; Breimer DD; Danysz W
Pharm Res; 1999 May; 16(5):637-42. PubMed ID: 10350004
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
Umino A; Takahashi K; Nishikawa T
Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
[TBL] [Abstract][Full Text] [Related]
10. Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats.
Potschka H; Fedrowitz M; Löscher W
Eur J Pharmacol; 1999 Jun; 374(2):175-87. PubMed ID: 10422758
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute and chronic lithium treatment on amphetamine-induced dopamine increase in the nucleus accumbens and prefrontal cortex in rats as studied by microdialysis.
Baptista T; Teneúd L; Contreras Q; Burguera JL; Burguera M; Hernández L
J Neural Transm Gen Sect; 1993; 94(2):75-89. PubMed ID: 7509157
[TBL] [Abstract][Full Text] [Related]
12. Chronic clozapine selectively decreases prefrontal cortex dopamine as shown by simultaneous cortical, accumbens, and striatal microdialysis in freely moving rats.
Hernandez L; Hoebel BG
Pharmacol Biochem Behav; 1995 Nov; 52(3):581-9. PubMed ID: 8545478
[TBL] [Abstract][Full Text] [Related]
13. Therapeutically relevant plasma concentrations of memantine produce significant L-N-methyl-D-aspartate receptor occupation and do not impair learning in rats.
Morè L; Gravius A; Nagel J; Valastro B; Greco S; Danysz W
Behav Pharmacol; 2008 Oct; 19(7):724-34. PubMed ID: 18797249
[TBL] [Abstract][Full Text] [Related]
14. N-methyl-d-aspartate receptors modulate extracellular dopamine concentration and metabolism in rat hippocampus and striatum in vivo.
Whitton PS; Maione S; Biggs CS; Fowler LJ
Brain Res; 1994 Jan; 635(1-2):312-6. PubMed ID: 8173968
[TBL] [Abstract][Full Text] [Related]
15. Concentration-dependent dual action of locally applied N-methyl-D-aspartate on extracellular dopamine in the rat prefrontal cortex in vivo.
Feenstra MG; van der Weij W; Botterblom MH
Neurosci Lett; 1995 Dec; 201(2):175-8. PubMed ID: 8848246
[TBL] [Abstract][Full Text] [Related]
16. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
[TBL] [Abstract][Full Text] [Related]
17. How can an inert gas counterbalance a NMDA-induced glutamate release?
Vallee N; Rostain JC; Risso JJ
J Appl Physiol (1985); 2009 Dec; 107(6):1951-8. PubMed ID: 19696368
[TBL] [Abstract][Full Text] [Related]
18. Adaptations of NMDA and dopamine D2, but not of muscarinic receptors following 14 days administration of uncompetitive NMDA receptor antagonists.
Hesselink MB; De Boer AG; Breimer DD; Danysz W
J Neural Transm (Vienna); 1999; 106(5-6):409-21. PubMed ID: 10443547
[TBL] [Abstract][Full Text] [Related]
19. Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats.
Tucci S; Fernandez R; Baptista T; Murzi E; Hernandez L
Brain Res Bull; 1994; 35(2):125-33. PubMed ID: 7953768
[TBL] [Abstract][Full Text] [Related]
20. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats.
Bubser M; Keseberg U; Notz PK; Schmidt WJ
Eur J Pharmacol; 1992 Dec; 229(1):75-82. PubMed ID: 1361915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
